Amgen and Duke Clinical Research Institute initiated first large-scale registry to evaluate real-world lipid management
On Nov. 15, 2019, Amgen in collaboration with the Duke Clinical Research Institute (DCRI) announced plans to initiate…
-
-
Seqirus’ Next Generation Cell-based Influenza Vaccine Shows Significantly Greater Effectiveness Compared to Standard Egg-based Options in the 2017-18 US Influenza Season
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
-
Boykin Family Pledges $10 million to Cleveland Clinic’s Taussig Cancer Institute
On May 18, 2018, the Boykin family pledged $10 million to support Cleveland Clinic’s Taussig Cancer Institute. Paula…
-
Biotechnology | CDC | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
CDC published ACIP recommendations for use of herpes zoster vaccines
On Jan. 26, 2018, the U.S. Centers for Disease Control and Prevention’ (CDC) Immunization Practices Advisory Committee (ACIP)…
-
Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer Institute
On Oct. 17, 2017, Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer…
-
Seqirus announced major advances in pandemic preparedness
On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…
-
SpringWorks Therapeutics was founded
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
-
The Tardigrade Genome was Sequenced, world first
On Nov. 25, 2015, scientists from the University of North Carolina at Chapel Hill announced they had sequenced…
-
Nobel Prize in Chemistry for 2015 awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar
On Oct. 7, 2015, the Nobel Prize in Chemistry for 2015 was awarded to Tomas Lindahl, Francis Crick…
-
RTP announced plans for a $50 million redevelopment
On Oct. 1, 2015 the President and CEO of the Research Triangle Foundation (RTP), Bob Geolas, announced RTP’s…
-
BioCryst’s RAPIVAB(TM) (peramivir injection) received FDA approval for treatment of influenza in adults
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…
-
The North Carolina Eshelman School of Pharmacy received $100 million donation from Fred Eshelman
On Dec. 3, 2014, Fred Eshelman, CEO and founder of Wilmington-based PPD Inc. and a member of the…
-
David H Murdock announced endowment for DHMRI
On Sept. 30, 2014, David H. Murdock, owner and chair of Castle & Cooke, and builder and founder…
-
Grifols opened state-of-the-art facility in Clayton to advance treatment of rare and life-threatening diseases
On Jun. 17, 2014, Grifols celebrated the grand opening of its new state-of-the-art North Fractionation Facility (NFF) in…
-
Myron Cohen received the North Carolina Award for Science
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
-
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
-
The Belly Button Biodiversity project was launched
On Jan. 3, 2011, the Belly Button Biodiversity project was launched to investigate the microbes inhabiting our navels…
-
HHS awarded a $487 million contract to Novartis to build a facility to manufacture cell-based influenza vaccine
On Jan. 15, 2009, the U.S. Dept. of Health and Human Services (HHS) awarded Novartis a $487 million…
-
The North Carolina School of Pharmacy was renamed in honor of Fred Eshelman
On May 21, 2008, the North Carolina School of Pharmacy was renamed the Eshelman School of Pharmacy in…
-
Oliver Smithies was awarded the 2007 Nobel Prize in Physiology or Medicine
On Oct. 8, 2007, the Nobel Prize in Physiology or Medicine was awarded jointly to Oliver Smithies from…
-
David H Murdock donated $35 million to Duke University to fund the Measurement to Understand the Reclassification of Disease
On Sept. 24, 2007, Duke University announced it will receive $35 million from billionaire real estate developer David…
-
Groundbreaking was held for the North Carolina Research Campus
On Feb. 23, 2006, groundbreaking was held for the first building of the North Carolina Research Campus (NCRC),…
-
The CDC activated its Emergency Operations Center for Tropical Storm Ernesto
Aug. 24, 2024, the U.S. Centers for Disease Control and Prevention (CDC) activated its Emergency Operations Center (EOC)…
-
David H Murdock announced a $1.5 billion North Carolina Research Campus
On Sept. 12, 2005, David H. Murdock announced a $1.5 billion scientific and economic revitalization project called the…
-
David H Murdock purchased the former Cannon Mills site at auction, future home of the North Carolina Research Campus
In Dec. 2004, David H. Murdock purchased the former Cannon Mills site at auction, future home of the…
-
Biotechnology | HIV | Infectious Disease | NIH | Vaccine
$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
-
Duke heads $37 million trial of exercise for heart failure
On Apr. 15, 2003, the National Heart Lung Blood Institute (NHLB) announced a $37 million trial, coordinated by…
-
The Priestley Medal was awarded to Ernest L. Eliel
In 1996, the American Chemical Society awarded the Priestley Medal to Ernest L. Eliel ‘for his numerous contributions…
-
The Biotechnology Industry Organization was created by the merger of IBA and the ABC
On Jul. 1, 1993, the Biotechnology Industry Organization (BIO) was created through the merger of the Industrial Biotechnology…
-
The costs of influenza vaccine and its administration became a covered benefit under Medicare Part B
On May 1, 1993, the costs of influenza vaccine and its administration became a covered benefit under Medicare…
